Dental Care Clinics in White Hall, AR Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Donna D. Massey D.d.s. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 7215 Sheridan Rd, White Hall, AR 71602 Phone: 870-535-4050 Fax: 870-535-2819 |
Small Bites Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 7197 Sheridan Rd Ste 115, White Hall, AR 71602 Phone: 870-267-1423 |
Hathaway Family Dentistry, P.a. Dentist Medicare: Not Enrolled in Medicare Practice Location: 8426 Dollarway Rd, White Hall, AR 71602 Phone: 501-626-1830 |
Terry L Boone Dds, Pa Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 7197 Sheridan Rd Ste 115, White Hall, AR 71602 Phone: 870-267-1423 |
News Archive
Siemens Healthcare renews strategic alliance with NextGen Healthcare Information Systems
Today, Siemens Healthcare announced it has renewed its strategic alliance with NextGen Healthcare Information Systems to deliver innovative ambulatory information technology (IT) solutions. More than 35 Siemens customers have already deployed NextGen Healthcare's ambulatory IT tools throughout their physician networks as a result of the relationship, formed to offer healthcare providers interoperable solutions that cross the care coordination gap between the acute and ambulatory environments.
Medicare cuts, competing views on overhaul keep health issues hot in campaign
"Obamacare cuts Medicare -; cuts Medicare -; by approximately $500 billion," Mr. Romney has told audiences. That is a reprise of Republicans' mantra of the 2010 midterm elections, which gave them big gains at both the state and federal levels and a majority in the House.
Tips for prevention and early detection of skin cancer
According to the American Cancer Society, an estimated 82,770 Americans will be diagnosed this year with skin cancer, including melanoma. When left untreated, melanoma is the most dangerous and aggressive form of skin cancer, accounting for more than 9,000 of the 12,000-plus skin cancer deaths each year.
Results of IES presented at ECCO
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
Research reveals curious pattern of autism recurrence based on gender
Having one child with autism is a well-known risk factor for having another one with the same disorder, but whether and how a sibling's gender influences this risk has remained largely unknown.
› Verified 6 days ago